Erratum to “Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer” [Lung Cancer 76 (1) (2012) 32–38](S0169500211005150)(10.1016/j.lungcan.2011.10.002);Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

Lung Cancer

Volumn 76, Issue 1, 2012, Pages 32-38

  Tanaka, Norimitsu ^a   Toyooka, Shinichi ^a   Soh, Junichi ^a   Kubo, Takafumi ^a   Yamamoto, Hiromasa ^a,b   Maki, Yuho ^a   Muraoka, Takayuki ^a   Shien, Kazuhiko ^a   Furukawa, Masashi ^a   Ueno, Tsuyoshi ^a   Asano, Hiroaki ^a   Tsukuda, Kazunori ^a   Aoe, Keisuke ^b   Miyoshi, Shinichiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

Author keywords

Methylation; MicroRNA; MicroRNA 34b c; Non small cell lung cancer; P53; Small cell lung cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MICRORNA; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CARCINOGENICITY; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GENE FREQUENCY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA METHYLATION; WESTERN BLOTTING;

EID: 84858006067     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.04.016     Document Type: Erratum

References (28)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Tyczynski J.E., Bray F., Parkin D.M. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003, 4:45-55.
3. Huisman C., Postmus P.E., Giaccone G., Smit E.F. Second-line chemotherapy and its evaluation in small cell lung cancer. Cancer Treat Rev 1999, 25:199-206.
4. Amarasena I.U., Walters J.A., Wood-Baker R., Fong K. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev 2008, CD006849.
5. Hann C.L., Rudin C.M. Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer. Trends Mol Med 2007, 13:150-157.
6. Landi M.T., Zhao Y., Rotunno M., Koshiol J., Liu H., Bergen A.W., et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010, 16:430-441.
7. Wistuba I.I., Berry J., Behrens C., Maitra A., Shivapurkar N., Milchgrub S., et al. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res 2000, 6:2604-2610.
8. Wistuba I.I., Gazdar A.F., Minna J.D. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001, 28:3-13.
9. Tatematsu A., Shimizu J., Murakami Y., Horio Y., Nakamura S., Hida T., et al. Epidermal growth factor receptor mutations in small cell lung cancer. Clin Cancer Res 2008, 14:6092-6096.
10. Toyooka S., Mitsudomi T., Soh J., Aokage K., Yamane M., OtoT, et al. Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg 2011, 59:527-537.
11. Salgia R., Skarin A.T. Molecular abnormalities in lung cancer. J Clin Oncol 1998, 16:1207-1217.
12. Helmbold P., Lahtz C., Herpel E., Schnabel P.A., Dammann R.H. Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 2009, 45:2207-2211.
13. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
14. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
15. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
16. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007, 12:414-418.
17. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
18. Wang Z., Chen Z., Gao Y., Li N., Li B., Tan F., et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer. Cancer Biol Ther 2011, 11:490-496.
19. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007, 17:1298-1307.
20. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008, 68:4123-4132.
21. Casey G., Lopez M.E., Ramos J.C., Plummer S.J., Arboleda M.J., Shaughnessy M., et al. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 1996, 13:1971-1981.
22. Hashimoto T., Tokuchi Y., Hayashi M., Kobayashi Y., Nishida K., Hayashi S., et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 1999, 59:5572-5577.
23. Katayama H., Hiraki A., Aoe K., Fujiwara K., Matsuo K., Maeda T., et al. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Int J Cancer 2007, 120:2191-2195.
24. Corney D.C., Hwang C.I., Matoso A., Vogt M., Flesken-Nikitin A., Godwin A.K., et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 2010, 16:1119-1128.
25. Kubo T., Toyooka S., Tsukuda K., Sakaguchi M., Fukazawa T., Soh J., et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011, 17:4965-4974.
26. Giordano S., Ponzetto C., Di Renzo M.F., Cooper C.S., Comoglio P.M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989, 339:155-156.
27. Rygaard K., Nakamura T., Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer 1993, 67:37-46.
28. Maulik G., Kijima T., Ma P.C., Ghosh S.K., Lin J., Shapiro G.I., et al. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res 2002, 8:620-627.